Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 21, 2015; 21(11): 3245-3255
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3245
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3245
Table 1 Association of miR-1290 upregulation with clinicopathological characteristics of 24 patients with esophageal squamous cell carcinoma
| Characteristic | Total(n = 24) | miR-1290 Expression | P value | |
| Low | High | |||
| Age | ||||
| < 60 | 12 | 5 | 7 | 0.682 |
| ≥ 60 | 12 | 6 | 6 | |
| Gender | ||||
| Female | 10 | 5 | 5 | 0.729 |
| Male | 14 | 6 | 8 | |
| Differentiation | ||||
| High | 13 | 3 | 10 | 0.021 |
| Middle + Low | 11 | 8 | 3 | |
| T Classification | ||||
| T1 + T2 | 10 | 3 | 7 | 0.240 |
| T3 + T4 | 14 | 8 | 6 | |
| N Classification | ||||
| N0 | 13 | 3 | 10 | 0.006 |
| N1-N3 | 11 | 8 | 3 | |
| TNM Stage | ||||
| Ⅰ+Ⅱ | 15 | 4 | 11 | 0.021 |
| Ⅲ | 9 | 7 | 2 | |
- Citation: Li M, He XY, Zhang ZM, Li S, Ren LH, Cao RS, Feng YD, Ji YL, Zhao Y, Shi RH. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis. World J Gastroenterol 2015; 21(11): 3245-3255
- URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3245.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i11.3245